Stephan Marticorena Garcia

Dr. Stephan Marticorena Garcia

Charitè – Universitätsmedizin Berlin
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2018 in Ultraschall in der Medizin - European Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
AMAndreas Maxeiner
Andreas Maxeiner
TFThomas Fischer
Thomas Fischer
JSJulia Schwabe
Julia Schwabe
ABAlexander Daniel Jacques Baur
Alexander Daniel Jacques Baur
CSCarsten Stephan
Carsten Stephan
EJErnst-Michael Jung
Ernst-Michael Jung
Purpose The aim of this study was to investigate contrast-enhanced ultrasound (CEUS) parameters acquired by software during magnetic resonance imaging (MRI) US fusion-guided biopsy for prostate cancer (PCa) detection and discrimination. Materials and Methods From 2012 to 2015, 158 out of 165 men with suspicion for PCa and with at least 1 negative biopsy of the prostate were included and underwent a multi-parametric 3 Tesla MRI and an MRI/US fusion-guided biopsy, consecutively. CEUS was conducted during biopsy with intravenous bolus application of 2.4 mL of SonoVue® (Bracco, Milan, Italy). In the latter CEUS clips were investigated using quantitative perfusion analysis software (VueBox, Bracco). The area of strongest enhancement within the MRI pre-located region was investigated and all available parameters from the quantification tool box were collected and analyzed for PCa and its further differentiation was based on the histopathological results. Results The overall detection rate was 74 (47 %) PCa cases in 158 included patients. From these 74 PCa cases, 49 (66 %) were graded Gleason ≥ 3 + 4 = 7 (ISUP ≥ 2) PCa. The best results for cancer detection over all quantitative perfusion parameters were rise time (p = 0.026) and time to peak (p = 0.037). Within the subgroup analysis (> vs ≤ 3 + 4 = 7a (ISUP 2)), peak enhancement (p = 0.012), wash-in rate (p = 0.011), wash-out rate (p = 0.007) and wash-in perfusion index (p = 0.014) also showed statistical significance. Conclusion The quantification of CEUS parameters was able to discriminate PCa aggressiveness during MRI/US fusion-guided prostate biopsy. Ziel Die Aussagekraft einzelner Parameter der Kontrastmittel gestützten Sonografie (CEUS) soll hinsichtlich der Detektion des Prostatakarzinoms und der Möglichkeit einer Aggressivitäts Unterscheidung bewertet werden. Material und Methoden Im Untersuchungszeitraum von 2012 und 2014 wurden 158 von insgesamt 165 Patienten mit mindestens einer vorausgegangenen negativen Prostatastanzbiopsie eingeschlossen und erhielten eine multiparametrische 3 T (Magnetresonanztomografie) mpMRT und konsekutiv eine MRT/US fusionierte Biopsie. Während der MRT/US-Fusion wurde nach Gabe von 2,4 ml SonoVue® (Bracco, Milan, Italy) die CEUS Untersuchung durchgeführt. Die gespeicherten Filme wurden doppelblind mittels quantitativer Perfusionsanalysesoftware (VueBox, Bracco, Milano) ausgewertet. Die Region in der MRT-Läsion mit der stärksten KM-Anreicherung wurde als führende ROI (region of interest) untersucht und alle gewonnen Parameter wurden auf das Vorliegen eines Prostatakarzinoms und Differenzierung in unterschiedliche Aggressivitätsgrade im Abgleich mit den histologischen Ergebnissen ausgewertet. Ergebnisse Die Gesamtdetektionsrate von Prostatakarzinomen innerhalb der Kohorte betrug 74 (48 %) von 158 Patienten. Die besten Ergebnisse unter allen quantitativen CEUS Parametern in Bezug auf die Prostatakarzinomdetektion zeigten bei folgenden Parametern: rise time (p = 0,026) und time to peak (p = 0,037). Im Rahmen der Aggressivitäts Diskriminierung insbesondere in einer Subgruppenanalyse (> vs ≤ 3 + 4 = 7a (ISUP 2)), imponierten peak enhancement (p = 0,012), wash-in rate (p = 0,011), wash-out rate (p = 0,007) und wash-in perfusion index (p = 0,014) als statistisch signifikant. Schlussfolgerung Die Analyse einzelner Quantifikationsparameter der CEUS zeigte sowohl das Potential einer Detektion von Prostatakarzinomen als auch der Diskriminierung zwischen klinisch signifikanter und nicht signifikanter Karzinome. # These authors contributed equally

1 September 2016 in Investigative Radiology
Verified
Journal Article
Closed access
SGStephan Marticorena Garcia
Stephan Marticorena Garcia
TFThomas Fischer
Thomas Fischer
MDMichael Duerr
Michael Duerr
EGEmin Gültekin
Emin Gültekin
JBJürgen Braun
Jürgen Braun
JGJing Guo
Jing Guo
Objective: The aim of this study was to apply multifrequency magnetic resonance elastography (MMRE) for assessment of kidney function based on renal stiffness of allografts in transplant recipients and native kidneys in controls. Methods: In this prospective study, MMRE was used to measure stiffness in transplant kidneys in 22 recipients (age range, 23–73 years; 7 females) and in native kidneys in 11 controls (age range, 26–55 years; 4 females) after internal review board approval. The MMRE was performed on a 1.5 T magnetic resonance imaging scanner using 4 vibration frequencies from 40 to 70 Hz. Stiffness maps were computed by multifrequency reconstruction of the magnitude shear modulus (|G*|). Clinical markers such as glomerular filtration rate (GFR) and resistive index (RI) were acquired. Differences in renal stiffness among groups were compared by Mann-Whitney U test. Correlations were tested using Pearson correlation. Results: Functioning transplants had higher stiffness (|G*| = 9.00 ± 1.71 kPa) than nonfunctioning transplants (|G*| = 5.88 ± 1.71 kPa, P < 0.001) and native kidneys (|G*| = 6.63 ± 1.63 kPa, P < 0.01). A cutoff value of 7.04 kPa provided sensitivity (83.33%) and specificity (86.67%) for detecting renal allograft dysfunction with an area under the receiver operating characteristic curve value of 0.9278 (95% confidence interval, 0.83–1.00). |G*| correlated positively with GFR (r = 0.52, P = 0.015) and negatively with RI (r = −0.52, P = 0.016). Conclusions: Multifrequency magnetic resonance elastography has good diagnostic accuracy in detecting renal allograft dysfunction. Renal stiffness is significantly lower in recipients with nonfunctioning transplant kidneys and correlates with clinical markers such as GFR and RI.

30 August 2017 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
SGStephan Marticorena Garcia
Stephan Marticorena Garcia
MGMarkus Grossmann
Markus Grossmann
SLSophia Theresa Lang
Sophia Theresa Lang
HTHeiko Tzschätzsch
Heiko Tzschätzsch
FDFlorian Dittmann
Florian Dittmann
ISIngolf Sack
Ingolf Sack

22 April 2015 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
CAChristian E. Althoff
Christian E. Althoff
MBMatthias Bollow
Matthias Bollow
EFEugen Feist
Eugen Feist
SGStephan Marticorena Garcia
Stephan Marticorena Garcia
IEIris Eshed
Iris Eshed
Kay Geert HermannKay Geert Hermann
Kay Geert Hermann

1 June 2016 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
SISelcan Ipek-Ugay
Selcan Ipek-Ugay
HTHeiko Tzschätzsch
Heiko Tzschätzsch
CHChristian Hudert
Christian Hudert
SGStephan Marticorena Garcia
Stephan Marticorena Garcia
TFThomas Fischer
Thomas Fischer
ISIngolf Sack
Ingolf Sack

1 February 2019 in Investigative Radiology
Verified
Journal Article
Closed access
SGStephan Marticorena Garcia
Stephan Marticorena Garcia
MGMarkus Grossmann
Markus Grossmann
ABAnne Bruns
Anne Bruns
MDMichael Dürr
Michael Dürr
HTHeiko Tzschätzsch
Heiko Tzschätzsch
JGJing Guo
Jing Guo
Objectives: The aim of this study was to test multiparametric magnetic resonance imaging including blood oxygen level–dependent (BOLD) imaging by T2* mapping, magnetic resonance elastography (MRE) by tomoelastography, and diffusion-weighted imaging (DWI) for detecting nephropathy in patients with lupus nephritis (LN). Methods: Forty-one subjects (25 patients with LN and 16 age- and sex-matched healthy volunteers; LN: mean age, 47.3 ± 14.8 years; 22 female subjects; volunteers: mean age, 43.9 ± 11.6 years; 13 female subjects) were prospectively enrolled. The LN group was further divided into subgroups with normal (LN-nRF, GFR > 90 mL/min per 1.73 m2) and compromised renal function (LN-cRF, GFR < 90 mL/min per 1.73 m2). All subjects were examined by multifrequency MRE, BOLD imaging, and DWI, yielding shear wave speed (SWS; in meter per second), T2* relaxation times (in millisecond), and apparent diffusion coefficient (ADC; in millimeter square per second), respectively. Renal subregional analysis was performed for the medulla (ME), inner cortex (CoI), and outer cortex (CoO). Imaging markers were correlated to clinical parameters such as GFR and protein-to-urine creatinine ratio. Cutoffs and area under the receiver operating curve (AUROC) were computed to test diagnostic performances. Results: Compared with CoI and CoO, LN-nRF predominantly affects ME tissue (SWS: −7%, P < 0.01; T2*: +9%, P < 0.05; ADC: −5%, P = 0.27). Detection of LN-nRF was better with MRE compared with BOLD imaging and DWI (AUROC = 0.81, 0.76, not significant), whereas pairing MRE with T2* further increased diagnostic power (AUROC = 0.91). Disease progression was associated with reduction of SWS also in CoI (LN-nRF, 3.04 ± 0.38 m/s; LN-cRF, 2.60 ± 0.26 m/s; p = 0.013), allowing distinction of LN-nRF from LN-cRF (AUROC = 0.83). Diffusion-weighted imaging was only sensitive to LN-cRF in ME tissue (ADC, –12%; P < 0.05). Conclusions: Lupus nephritis with normal renal function first arises in MRE and BOLD images within ME tissue, progressing to CoI tissue once renal function becomes impaired and diffusion of tissue water changes.